文献库搜索 | GeneLibs

Zhao(F),Lin(H),Han(R),Wang(M),Yang(L),Tian... BMC Cancer 2026-03-10

...BRCA2 and ATM mutations exceeded 10. CONCLUSIONS: Our findings offer a comprehensive overview of genetic susceptibility ...

Mashal(S),Melanson(A),Apostolova(C),Ferrou... Ann Surg Oncol 2026-06-00

...BRCA2, and 21 (4.4%) in PALB2. The median age at genetic testing was 37 years (interquartile range [IQR], 29-47) and 365...

Kawahara(S),Taki(M),Hamanishi(J),Ebara(S),... Mol Cancer Ther 2026-03-12

...BRCA2, induced apoptosis and DNA damage, and inhibited tumor growth in USC PDX models with high CDK12 expression. Furthe...

Saule(C),Laas(E),Weber(N),Bataillon(G),Bec... Gynecol Oncol 2026-05-00

...BRCA2 METHODS: We conducted an ambispective multicenter study in France including 1351 women at high risk of ovarian can...

Laitman(Y),Zalmanoviz(S),Netzer(I),Bernste... Cancer Genet 2026-06-00

...BRCA2, MSH2, and MSH6 genes, has not been reported. Individuals who underwent MGPT after oncogenetic counseling between ...

Marques(A),Mas(L),Dardenne(A),Paye(F),Andr... Bull Cancer 2026-06-00

...BRCA2, which may offer an opportunity for genetic counselling. Other molecular alterations, such as BRAF (approximately ...

Khan(NU),Lei(H),Fu(J),Lei(R),Chen(X),Alqar... J Transl Med 2026-03-12

...BRCA2) are critical genes associated with hereditary breast cancer, and their mutation prevalence might greatly vary acr...

Hawsawi(YM),Mansoor(I),Sayan(M),Alsaleem(M... Int J Surg Pathol 2026-08-00

...BRCA2. To clarify the clinicopathological impact of somatic PALB2 variants, we analyzed tumor DNA extracted from formali...

Tooming(M),Toome(K),Rekker(K),Roht(L),Laid... Sci Rep 2026-03-13

...BRCA2 (3.8%; 4.5%), and CHEK2 (3.5%; 1.7%). Two BRCA1 PV, c.5266dup and c.4035del, accounted for 29.1% of all PV detecte...

Wiesmeier(A),Prantl(L),Zemann(F),Eisenmann... J Clin Med 2026-03-09

...BRCA2. Patients who opt for breast removal are offered tailored reconstructive options based on their medical history an...